Detalles de la búsqueda
1.
Association of homogeneous inflamed gene signature with a better outcome in patients with metastatic melanoma treated with MAGE-A3 immunotherapeutic.
ESMO Open
; 3(5): e000384, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30094070
2.
Safety and immunogenicity of MAGE-A3 cancer immunotherapeutic with dacarbazine in patients with MAGE-A3-positive metastatic cutaneous melanoma: an open phase I/II study with a first assessment of a predictive gene signature.
ESMO Open
; 2(5): e000203, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29177094
3.
Adjuvant MAGE-A3 immunotherapy in resected non-small-cell lung cancer: phase II randomized study results.
J Clin Oncol
; 31(19): 2396-403, 2013 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23715567
Resultados
1 -
3
de 3
1
Próxima >
>>